These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21270265)

  • 21. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
    Mayer F; Gunawan AL; Tso P; Aponte GW
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GIP-like immunoreactivity in glucagon cells. Interactions between GIP and glucagon on insulin release.
    Ahrén B; Håkanson R; Lundquist I; Sjölund K; Sundler F
    Acta Physiol Scand; 1981 Jul; 112(3):233-42. PubMed ID: 7027739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose-dependent Insulinotropic Polypeptide (GIP): From prohormone to actions in endocrine pancreas and adipose tissue.
    Ugleholdt R
    Dan Med Bull; 2011 Dec; 58(12):B4368. PubMed ID: 22142579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GIP(3-30)NH
    Gasbjerg LS; Christensen MB; Hartmann B; Lanng AR; Sparre-Ulrich AH; Gabe MBN; Dela F; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
    Diabetologia; 2018 Feb; 61(2):413-423. PubMed ID: 28948296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties.
    Wheeler MB; Gelling RW; McIntosh CH; Georgiou J; Brown JC; Pederson RA
    Endocrinology; 1995 Oct; 136(10):4629-39. PubMed ID: 7664683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional factor Pdx1 is involved in age-related GIP hypersecretion in mice.
    Ikeguchi E; Harada N; Kanemaru Y; Sankoda A; Yamane S; Iwasaki K; Imajo M; Murata Y; Suzuki K; Joo E; Inagaki N
    Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G272-G282. PubMed ID: 29723041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of glucose-dependent insulinotropic polypeptide and its receptor in the retina of streptozotocin-induced diabetic rats.
    Cho GJ; Ryu S; Kim YH; Kim YS; Cheon EW; Park JM; Kim HJ; Kang SS; Choi WS
    Curr Eye Res; 2002 Dec; 25(6):381-8. PubMed ID: 12789546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose-dependent insulinotropic polypeptide gene expression in the stomach: revealed by a transgenic mouse study, in situ hybridization and immunohistochemical staining.
    Yeung CM; Wong CK; Chung SK; Chung SS; Chow BK
    Mol Cell Endocrinol; 1999 Aug; 154(1-2):161-70. PubMed ID: 10509810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incretin hormones regulate microglia oxidative stress, survival and expression of trophic factors.
    Spielman LJ; Gibson DL; Klegeris A
    Eur J Cell Biol; 2017 May; 96(3):240-253. PubMed ID: 28336086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of regulator of G protein signaling in desensitization of the glucose-dependent insulinotropic peptide receptor.
    Tseng CC; Zhang XY
    Endocrinology; 1998 Nov; 139(11):4470-5. PubMed ID: 9794454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors.
    Younan SM; Rashed LA
    Gen Physiol Biophys; 2007 Sep; 26(3):181-93. PubMed ID: 18063845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
    Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologic and pharmacologic modulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta-cells by peroxisome proliferator-activated receptor (PPAR)-gamma signaling: possible mechanism for the GIP resistance in type 2 diabetes.
    Gupta D; Peshavaria M; Monga N; Jetton TL; Leahy JL
    Diabetes; 2010 Jun; 59(6):1445-50. PubMed ID: 20332343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion.
    Jia X; Brown JC; Ma P; Pederson RA; McIntosh CH
    Am J Physiol; 1995 Apr; 268(4 Pt 1):E645-51. PubMed ID: 7733263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor.
    Ugleholdt R; Poulsen ML; Holst PJ; Irminger JC; Orskov C; Pedersen J; Rosenkilde MM; Zhu X; Steiner DF; Holst JJ
    J Biol Chem; 2006 Apr; 281(16):11050-7. PubMed ID: 16476726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The equine glucose-dependent insulinotropic polypeptide receptor: A potential therapeutic target for insulin dysregulation.
    Kheder MH; Sillence MN; Bryant LM; de Laat MA
    J Anim Sci; 2017 Jun; 95(6):2509-2516. PubMed ID: 28727072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The enteroinsular axis in dipeptidyl peptidase IV-negative rats.
    Pederson RA; Kieffer TJ; Pauly R; Kofod H; Kwong J; McIntosh CH
    Metabolism; 1996 Nov; 45(11):1335-41. PubMed ID: 8931636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice.
    Tura A; Pacini G; Yamada Y; Seino Y; Ahrén B
    Am J Physiol Regul Integr Comp Physiol; 2019 Jan; 316(1):R27-R37. PubMed ID: 30462524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
    Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
    Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.